NO161800C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler.

Info

Publication number
NO161800C
NO161800C NO844420A NO844420A NO161800C NO 161800 C NO161800 C NO 161800C NO 844420 A NO844420 A NO 844420A NO 844420 A NO844420 A NO 844420A NO 161800 C NO161800 C NO 161800C
Authority
NO
Norway
Prior art keywords
azoles
ethenyl
halo
aryl
preparation
Prior art date
Application number
NO844420A
Other languages
English (en)
Norwegian (no)
Other versions
NO844420L (no
NO161800B (no
Inventor
Jan Heeres
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO844420L publication Critical patent/NO844420L/no
Publication of NO161800B publication Critical patent/NO161800B/no
Publication of NO161800C publication Critical patent/NO161800C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO844420A 1983-11-07 1984-11-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler. NO161800C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54912783A 1983-11-07 1983-11-07
US06/630,158 US4539325A (en) 1983-11-07 1984-07-12 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles, and anticonvulsant use thereof

Publications (3)

Publication Number Publication Date
NO844420L NO844420L (no) 1985-05-08
NO161800B NO161800B (no) 1989-06-19
NO161800C true NO161800C (no) 1989-09-27

Family

ID=27069019

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844420A NO161800C (no) 1983-11-07 1984-11-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler.

Country Status (17)

Country Link
US (1) US4539325A (xx)
EP (1) EP0142190B1 (xx)
JP (1) JPH0613480B2 (xx)
AU (1) AU566022B2 (xx)
CA (1) CA1241657A (xx)
CS (1) CS382091A3 (xx)
CY (1) CY1606A (xx)
DE (1) DE3478743D1 (xx)
DK (1) DK162984C (xx)
FI (1) FI85854C (xx)
HK (1) HK52591A (xx)
IE (1) IE57826B1 (xx)
IL (1) IL73425A (xx)
NO (1) NO161800C (xx)
NZ (1) NZ210014A (xx)
SG (1) SG46991G (xx)
SU (1) SU1322978A3 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690942A (en) * 1983-12-20 1987-09-01 Ciba-Geigy Corporation 1-aryl-2-fluoro-2-azolyl alkanones, alkanols, esters, and ethers, composition containing them, and use of them to control phytopathogenic microorganisms
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
JP2792694B2 (ja) * 1989-12-12 1998-09-03 エスケ−化研株式会社 塗布装置
US5302606A (en) * 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
US5418245A (en) * 1990-04-16 1995-05-23 Rhone-Poulenc Rorer International (Holdings) Inc. Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
WO2002045712A1 (en) * 2000-12-04 2002-06-13 Biovitrum Ab Novel method and use
SE0004462D0 (sv) 2000-12-04 2000-12-04 Pharmacia Ab Novel method and use
RU2632682C1 (ru) * 2016-09-30 2017-10-09 Федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Комплекс ацетата цинка с 1-пропаргилимидазолом, обладающий антигипоксической активностью

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679697A (en) * 1970-10-08 1972-07-25 Searle & Co 1-({62 -halophenethyl)imidazoles
GB1533705A (en) * 1975-03-10 1978-11-29 Ici Ltd Method of combating fungal infections in plants using imidazoles and 1,2,4-triazoles
DE2839388A1 (de) * 1978-09-11 1980-03-27 Siegfried Ag Imidazolylvinylaether und deren verwendung
NL8005204A (nl) * 1980-09-17 1982-04-16 Gist Brocades Nv Ethenyl-imidazool-derivaten met antimycotische werkzaamheid.
GR78234B (xx) * 1981-03-10 1984-09-26 Ciba Geigy Ag
CA1189857A (en) * 1981-03-27 1985-07-02 Janssen Pharmaceutica Naamloze Vennootschap Antimicrobial triazole derivatives
CA1206970A (en) * 1981-10-01 1986-07-02 Hak-Foon Chan Substituted ethylenic imidazoles and triazoles

Also Published As

Publication number Publication date
DK162984B (da) 1992-01-06
FI844349A0 (fi) 1984-11-06
FI844349L (fi) 1985-05-08
EP0142190A2 (en) 1985-05-22
DK528284D0 (da) 1984-11-06
NO844420L (no) 1985-05-08
SG46991G (en) 1991-07-26
EP0142190A3 (en) 1986-12-03
NZ210014A (en) 1987-03-06
JPS60166666A (ja) 1985-08-29
IE842852L (en) 1985-05-07
AU3513784A (en) 1985-05-16
JPH0613480B2 (ja) 1994-02-23
IL73425A (en) 1987-09-16
IL73425A0 (en) 1985-02-28
HK52591A (en) 1991-07-19
AU566022B2 (en) 1987-10-08
CS382091A3 (en) 1992-04-15
FI85854C (fi) 1992-06-10
US4539325A (en) 1985-09-03
CY1606A (en) 1992-04-03
IE57826B1 (en) 1993-04-21
FI85854B (fi) 1992-02-28
CA1241657A (en) 1988-09-06
DE3478743D1 (de) 1989-07-27
DK162984C (da) 1992-06-01
NO161800B (no) 1989-06-19
SU1322978A3 (ru) 1987-07-07
DK528284A (da) 1985-05-08
EP0142190B1 (en) 1989-06-21

Similar Documents

Publication Publication Date Title
NO163451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte trans-1,2-diamino-cykloheksylamidforbindelser.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO164301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO161800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO163529C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloalkaner.